25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

EIKO (Eiko Lifesciences Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Eiko Lifesciences Ltd together

I guess you are interested in Eiko Lifesciences Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Eiko Lifesciences Ltdโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Eiko Lifesciences Ltdโ€™s Price Targets

I'm going to help you getting a better view of Eiko Lifesciences Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Eiko Lifesciences Ltd

I send you an email if I find something interesting about Eiko Lifesciences Ltd.

1. Quick Overview

1.1. Quick analysis of Eiko Lifesciences Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Eiko Lifesciences Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR41.13
Expected worth in 1 year
INR59.39
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR18.26
Return On Investment
33.3%

For what price can you sell your share?

Current Price per Share
INR54.90
Expected price per share
INR48.52 - INR65.90
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Eiko Lifesciences Ltd (5 min.)




Live pricePrice per Share (EOD)
INR54.90
Intrinsic Value Per Share
INR-13.84 - INR-15.76
Total Value Per Share
INR27.29 - INR25.37

2.2. Growth of Eiko Lifesciences Ltd (5 min.)




Is Eiko Lifesciences Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$6.4m$5.7m$721.4k11.1%

How much money is Eiko Lifesciences Ltd making?

Current yearPrevious yearGrowGrow %
Making money$240k$85.6k$154.3k64.3%
Net Profit Margin5.8%2.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Eiko Lifesciences Ltd (5 min.)




2.4. Comparing to competitors in the Specialty Chemicals industry (5 min.)




  Industry Rankings (Specialty Chemicals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Eiko Lifesciences Ltd?

Welcome investor! Eiko Lifesciences Ltd's management wants to use your money to grow the business. In return you get a share of Eiko Lifesciences Ltd.

First you should know what it really means to hold a share of Eiko Lifesciences Ltd. And how you can make/lose money.

Speculation

The Price per Share of Eiko Lifesciences Ltd is INR54.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Eiko Lifesciences Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Eiko Lifesciences Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR41.13. Based on the TTM, the Book Value Change Per Share is INR4.57 per quarter. Based on the YOY, the Book Value Change Per Share is INR15.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Eiko Lifesciences Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.020.0%0.020.0%0.010.0%0.010.0%0.010.0%0.010.0%
Usd Book Value Change Per Share0.050.1%0.050.1%0.170.3%0.080.1%0.090.2%0.090.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.050.1%0.050.1%0.170.3%0.080.1%0.090.2%0.090.2%
Usd Price Per Share0.60-0.60-0.59-0.65-0.64-0.64-
Price to Earnings Ratio34.45-34.45-95.35-82.67-96.61-96.61-
Price-to-Total Gains Ratio11.46-11.46-3.42-43.17-28.12-28.12-
Price to Book Ratio1.27-1.27-1.41-1.93-3.06-3.06-
Price-to-Total Gains Ratio11.46-11.46-3.42-43.17-28.12-28.12-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.62586
Number of shares1597
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.09
Usd Total Gains Per Share0.050.09
Gains per Quarter (1597 shares)83.12149.76
Gains per Year (1597 shares)332.48599.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103323220599589
20665654011981188
30997986017971787
4013301318023962386
5016621650029952985
6019951982035943584
7023272314041934183
8026602646047924782
9029922978053915381
10033253310059905980

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.05.00.0%0.00.05.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Eiko Lifesciences Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.5664.5660%15.120-70%6.754-32%8.226-44%8.226-44%
Book Value Per Share--41.12941.1290%36.563+12%33.045+24%25.826+59%25.826+59%
Current Ratio--5.2475.2470%20.557-74%11.188-53%7.667-32%7.667-32%
Debt To Asset Ratio--0.1380.1380%0.039+252%0.076+80%0.131+5%0.131+5%
Debt To Equity Ratio--0.1600.1600%0.041+294%0.085+88%0.1600%0.1600%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--634368086.850634368086.8500%695981006.500-9%740988580.673-14%727582883.898-13%727582883.898-13%
Eps--1.5191.5190%0.542+180%0.874+74%0.717+112%0.717+112%
Ev To Sales Ratio--1.7611.7610%2.492-29%3.041-42%3.688-52%3.688-52%
Free Cash Flow Per Share---5.315-5.3150%-5.396+2%-2.599-51%-2.829-47%-2.829-47%
Free Cash Flow To Equity Per Share---5.315-5.3150%-5.396+2%-2.599-51%-2.829-47%-2.829-47%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---15.758----------
Intrinsic Value_10Y_min---13.843----------
Intrinsic Value_1Y_max---2.385----------
Intrinsic Value_1Y_min---2.317----------
Intrinsic Value_3Y_max---6.551----------
Intrinsic Value_3Y_min---6.198----------
Intrinsic Value_5Y_max---9.977----------
Intrinsic Value_5Y_min---9.211----------
Market Cap753277410.000+4%725317086.850725317086.8500%716585006.500+1%783574580.673-7%773838483.898-6%773838483.898-6%
Net Profit Margin--0.0580.0580%0.027+117%0.042+38%0.041+43%0.041+43%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio--1.8761.8760%1.8840%1.8830%1.874+0%1.874+0%
Pb Ratio1.335+5%1.2721.2720%1.414-10%1.925-34%3.062-58%3.062-58%
Pe Ratio36.137+5%34.44534.4450%95.354-64%82.671-58%96.608-64%96.608-64%
Price Per Share54.900+5%52.33052.3300%51.700+1%56.755-8%56.187-7%56.187-7%
Price To Free Cash Flow Ratio-10.328-5%-9.845-9.8450%-9.581-3%1.100-995%-23.634+140%-23.634+140%
Price To Total Gains Ratio12.025+5%11.46211.4620%3.419+235%43.172-73%28.123-59%28.123-59%
Quick Ratio--1.7211.7210%8.730-80%5.460-68%3.733-54%3.733-54%
Return On Assets--0.0320.0320%0.014+124%0.024+35%0.026+24%0.026+24%
Return On Equity--0.0370.0370%0.015+150%0.026+43%0.030+22%0.030+22%
Total Gains Per Share--4.5664.5660%15.120-70%6.754-32%8.226-44%8.226-44%
Usd Book Value--6498729.6006498729.6000%5777326.200+12%5210066.000+25%4064389.560+60%4064389.560+60%
Usd Book Value Change Per Share--0.0520.0520%0.172-70%0.077-32%0.094-44%0.094-44%
Usd Book Value Per Share--0.4690.4690%0.417+12%0.377+24%0.294+59%0.294+59%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--7231796.1907231796.1900%7934183.474-9%8447269.820-14%8294444.876-13%8294444.876-13%
Usd Eps--0.0170.0170%0.006+180%0.010+74%0.008+112%0.008+112%
Usd Free Cash Flow---839883.600-839883.6000%-852674.400+2%-412220.200-51%-445849.440-47%-445849.440-47%
Usd Free Cash Flow Per Share---0.061-0.0610%-0.062+2%-0.030-51%-0.032-47%-0.032-47%
Usd Free Cash Flow To Equity Per Share---0.061-0.0610%-0.062+2%-0.030-51%-0.032-47%-0.032-47%
Usd Market Cap8587362.474+4%8268614.7908268614.7900%8169069.074+1%8932750.220-7%8821758.716-6%8821758.716-6%
Usd Price Per Share0.626+5%0.5970.5970%0.589+1%0.647-8%0.641-7%0.641-7%
Usd Profit--240049.800240049.8000%85671.000+180%137788.000+74%112768.800+113%112768.800+113%
Usd Revenue--4107636.6004107636.6000%3183940.200+29%3126742.600+31%2737452.360+50%2737452.360+50%
Usd Total Gains Per Share--0.0520.0520%0.172-70%0.077-32%0.094-44%0.094-44%
 EOD+5 -3MRQTTM+0 -0YOY+23 -123Y+15 -205Y+14 -2110Y+14 -21

3.3 Fundamental Score

Let's check the fundamental score of Eiko Lifesciences Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.137
Price to Book Ratio (EOD)Between0-11.335
Net Profit Margin (MRQ)Greater than00.058
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.721
Current Ratio (MRQ)Greater than15.247
Debt to Asset Ratio (MRQ)Less than10.138
Debt to Equity Ratio (MRQ)Less than10.160
Return on Equity (MRQ)Greater than0.150.037
Return on Assets (MRQ)Greater than0.050.032
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Eiko Lifesciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose54.750
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Eiko Lifesciences Ltd

Eiko LifeSciences Limited manufactures and sells specialty and fine chemicals in India. The company operates through Specialty Chemicals; Pharma Intermidiates; Food Additives; Oleo Chemicals; and Cosmetic Ingredients segments. The company offers organic and inorganic specialty chemicals. Its products are used in pharmaceuticals, agrochemicals, aroma chemicals, electronic chemicals, etc. In addition, the company is involved in processing, formulating, producing, buying, selling, and exporting of specialty and fine chemicals. The company was formerly known as Narendra Investments (Delhi) Limited and changed its name to Eiko LifeSciences Limited in June 2021. Eiko LifeSciences Limited was incorporated in 1977 and is based in Thane, India.

Fundamental data was last updated by Penke on 2025-08-22 22:47:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Eiko Lifesciences Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compareย Eiko Lifesciences Ltd to theย Specialty Chemicals industry mean.
  • A Net Profit Margin of 5.8%ย means thatย ₹0.06 for each ₹1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Eiko Lifesciences Ltd:

  • The MRQ is 5.8%. The company is making a profit. +1
  • The TTM is 5.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.8%TTM5.8%0.0%
TTM5.8%YOY2.7%+3.2%
TTM5.8%5Y4.1%+1.7%
5Y4.1%10Y4.1%0.0%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8%3.6%+2.2%
TTM5.8%3.3%+2.5%
YOY2.7%3.7%-1.0%
3Y4.2%3.7%+0.5%
5Y4.1%5.4%-1.3%
10Y4.1%5.5%-1.4%
4.3.1.2. Return on Assets

Shows howย efficientย Eiko Lifesciences Ltd is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Eiko Lifesciences Ltd to theย Specialty Chemicals industry mean.
  • 3.2% Return on Assets means thatย Eiko Lifesciences Ltd generatedย ₹0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Eiko Lifesciences Ltd:

  • The MRQ is 3.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.2%TTM3.2%0.0%
TTM3.2%YOY1.4%+1.8%
TTM3.2%5Y2.6%+0.6%
5Y2.6%10Y2.6%0.0%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2%1.0%+2.2%
TTM3.2%0.8%+2.4%
YOY1.4%1.0%+0.4%
3Y2.4%1.0%+1.4%
5Y2.6%1.4%+1.2%
10Y2.6%1.5%+1.1%
4.3.1.3. Return on Equity

Shows how efficient Eiko Lifesciences Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Eiko Lifesciences Ltd to theย Specialty Chemicals industry mean.
  • 3.7% Return on Equity means Eiko Lifesciences Ltd generated ₹0.04ย for eachย ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Eiko Lifesciences Ltd:

  • The MRQ is 3.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.7%TTM3.7%0.0%
TTM3.7%YOY1.5%+2.2%
TTM3.7%5Y3.0%+0.7%
5Y3.0%10Y3.0%0.0%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%1.9%+1.8%
TTM3.7%1.5%+2.2%
YOY1.5%1.9%-0.4%
3Y2.6%1.9%+0.7%
5Y3.0%2.4%+0.6%
10Y3.0%2.6%+0.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Eiko Lifesciences Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Eiko Lifesciences Ltd is operatingย .

  • Measures how much profit Eiko Lifesciences Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Eiko Lifesciences Ltd to theย Specialty Chemicals industry mean.
  • An Operating Margin of 0.0%ย means the company generated ₹0.00 ย for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Eiko Lifesciences Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.2%-7.2%
TTM-5.3%-5.3%
YOY-5.6%-5.6%
3Y-3.7%-3.7%
5Y-6.6%-6.6%
10Y-7.0%-7.0%
4.3.2.2. Operating Ratio

Measures how efficient Eiko Lifesciences Ltd is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Specialty Chemicals industry mean).
  • An Operation Ratio of 1.88 means that the operating costs are ₹1.88 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Eiko Lifesciences Ltd:

  • The MRQ is 1.876. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.876. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.876TTM1.8760.000
TTM1.876YOY1.884-0.008
TTM1.8765Y1.874+0.003
5Y1.87410Y1.8740.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8761.484+0.392
TTM1.8761.448+0.428
YOY1.8841.047+0.837
3Y1.8831.199+0.684
5Y1.8741.101+0.773
10Y1.8741.051+0.823
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Eiko Lifesciences Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Eiko Lifesciences Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Specialty Chemicals industry mean).
  • A Current Ratio of 5.25ย means the company has ₹5.25 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Eiko Lifesciences Ltd:

  • The MRQ is 5.247. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.247. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.247TTM5.2470.000
TTM5.247YOY20.557-15.309
TTM5.2475Y7.667-2.420
5Y7.66710Y7.6670.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2471.738+3.509
TTM5.2471.804+3.443
YOY20.5571.862+18.695
3Y11.1881.883+9.305
5Y7.6671.918+5.749
10Y7.6671.926+5.741
4.4.3.2. Quick Ratio

Measures if Eiko Lifesciences Ltd is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Eiko Lifesciences Ltd to theย Specialty Chemicals industry mean.
  • A Quick Ratio of 1.72ย means the company can pay off ₹1.72 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Eiko Lifesciences Ltd:

  • The MRQ is 1.721. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.721. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.721TTM1.7210.000
TTM1.721YOY8.730-7.009
TTM1.7215Y3.733-2.011
5Y3.73310Y3.7330.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7210.790+0.931
TTM1.7210.835+0.886
YOY8.7300.961+7.769
3Y5.4600.981+4.479
5Y3.7331.060+2.673
10Y3.7331.136+2.597
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Eiko Lifesciences Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Eiko Lifesciences Ltdย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Eiko Lifesciences Ltd to Specialty Chemicals industry mean.
  • A Debt to Asset Ratio of 0.14ย means that Eiko Lifesciences Ltd assets areย financed with 13.8% credit (debt) and the remaining percentage (100% - 13.8%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of Eiko Lifesciences Ltd:

  • The MRQ is 0.138. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.138. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.138TTM0.1380.000
TTM0.138YOY0.039+0.099
TTM0.1385Y0.131+0.007
5Y0.13110Y0.1310.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1380.439-0.301
TTM0.1380.433-0.295
YOY0.0390.430-0.391
3Y0.0760.431-0.355
5Y0.1310.423-0.292
10Y0.1310.436-0.305
4.5.4.2. Debt to Equity Ratio

Measures ifย Eiko Lifesciences Ltd is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Eiko Lifesciences Ltd to theย Specialty Chemicals industry mean.
  • A Debt to Equity ratio of 16.0% means that company has ₹0.16 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Eiko Lifesciences Ltd:

  • The MRQ is 0.160. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.160. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.160TTM0.1600.000
TTM0.160YOY0.041+0.119
TTM0.1605Y0.1600.000
5Y0.16010Y0.1600.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1600.808-0.648
TTM0.1600.785-0.625
YOY0.0410.784-0.743
3Y0.0850.785-0.700
5Y0.1600.805-0.645
10Y0.1600.858-0.698
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every ₹1 in earnings Eiko Lifesciences Ltd generates.

  • Above 15 is considered overpriced butย always compareย Eiko Lifesciences Ltd to theย Specialty Chemicals industry mean.
  • A PE ratio of 34.45 means the investor is paying ₹34.45ย for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Eiko Lifesciences Ltd:

  • The EOD is 36.137. Based on the earnings, the company is overpriced. -1
  • The MRQ is 34.445. Based on the earnings, the company is overpriced. -1
  • The TTM is 34.445. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD36.137MRQ34.445+1.692
MRQ34.445TTM34.4450.000
TTM34.445YOY95.354-60.909
TTM34.4455Y96.608-62.163
5Y96.60810Y96.6080.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD36.13716.897+19.240
MRQ34.44515.492+18.953
TTM34.44516.173+18.272
YOY95.35416.993+78.361
3Y82.67117.761+64.910
5Y96.60819.814+76.794
10Y96.60824.323+72.285
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Eiko Lifesciences Ltd:

  • The EOD is -10.328. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.845. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.845. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.328MRQ-9.845-0.483
MRQ-9.845TTM-9.8450.000
TTM-9.845YOY-9.581-0.264
TTM-9.8455Y-23.634+13.789
5Y-23.63410Y-23.6340.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD-10.3286.055-16.383
MRQ-9.8455.339-15.184
TTM-9.8451.368-11.213
YOY-9.5813.426-13.007
3Y1.1001.686-0.586
5Y-23.6342.147-25.781
10Y-23.6342.927-26.561
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Eiko Lifesciences Ltd is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 1.27 means the investor is paying ₹1.27ย for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Eiko Lifesciences Ltd:

  • The EOD is 1.335. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.272. Based on the equity, the company is underpriced. +1
  • The TTM is 1.272. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.335MRQ1.272+0.062
MRQ1.272TTM1.2720.000
TTM1.272YOY1.414-0.142
TTM1.2725Y3.062-1.789
5Y3.06210Y3.0620.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD1.3351.741-0.406
MRQ1.2721.574-0.302
TTM1.2721.602-0.330
YOY1.4141.793-0.379
3Y1.9251.841+0.084
5Y3.0622.257+0.805
10Y3.0622.606+0.456
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets661,013
Total Liabilities90,949
Total Stockholder Equity567,886
 As reported
Total Liabilities 90,949
Total Stockholder Equity+ 567,886
Total Assets = 661,013

Assets

Total Assets661,013
Total Current Assets328,768
Long-term Assets332,248
Total Current Assets
Cash And Cash Equivalents 117,806
Net Receivables 107,858
Inventory 57,748
Other Current Assets 24
Total Current Assets  (as reported)328,768
Total Current Assets  (calculated)283,436
+/- 45,332
Long-term Assets
Property Plant Equipment 231,192
Long-term Assets  (as reported)332,248
Long-term Assets  (calculated)231,192
+/- 101,056

Liabilities & Shareholders' Equity

Total Current Liabilities62,654
Long-term Liabilities28,295
Total Stockholder Equity567,886
Total Current Liabilities
Short Long Term Debt 7,551
Accounts payable 33,147
Other Current Liabilities 17,918
Total Current Liabilities  (as reported)62,654
Total Current Liabilities  (calculated)58,616
+/- 4,038
Long-term Liabilities
Long term Debt 20,083
Long-term Liabilities  (as reported)28,295
Long-term Liabilities  (calculated)20,083
+/- 8,212
Total Stockholder Equity
Retained Earnings 55,055
Total Stockholder Equity (as reported)567,886
Total Stockholder Equity (calculated)55,055
+/- 512,831
Other
Capital Stock137,627
Common Stock Shares Outstanding 13,860
Net Invested Capital 595,520
Net Working Capital 266,114
Property Plant and Equipment Gross 259,542



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2025-03-312024-03-312023-03-312022-03-312021-03-31
> Total Assets 
166,140
348,937
310,428
527,387
661,013
661,013527,387310,428348,937166,140
   > Total Current Assets 
107,020
124,353
93,012
309,254
328,768
328,768309,25493,012124,353107,020
       Cash And Cash Equivalents 
2,008
2,173
6,124
133,460
117,806
117,806133,4606,1242,1732,008
       Short-term Investments 
24,723
2,283
0
0
0
0002,28324,723
       Net Receivables 
34,147
45,623
71,056
131,338
107,858
107,858131,33871,05645,62334,147
       Inventory 
635
54,575
9,076
33,857
57,748
57,74833,8579,07654,575635
   > Long-term Assets 
59,120
224,585
217,417
218,159
332,248
332,248218,159217,417224,58559,120
       Property Plant Equipment 
2,475
142,892
138,812
135,712
231,192
231,192135,712138,812142,8922,475
> Total Liabilities 
40,878
62,642
16,205
20,604
90,949
90,94920,60416,20562,64240,878
   > Total Current Liabilities 
39,598
60,061
11,987
15,044
62,654
62,65415,04411,98760,06139,598
       Short Long Term Debt 
16,306
45,741
536
0
7,551
7,551053645,74116,306
       Accounts payable 
18,950
13,485
10,453
13,805
33,147
33,14713,80510,45313,48518,950
       Other Current Liabilities 
0
499
543
1
17,918
17,91815434990
   > Long-term Liabilities 
1,280
2,581
4,218
5,560
28,295
28,2955,5604,2182,5811,280
       Long term Debt 
1,280
536
0
0
20,083
20,083005361,280
> Total Stockholder Equity
125,262
286,295
294,223
506,783
567,886
567,886506,783294,223286,295125,262
   Common Stock00000
   Retained Earnings 
11,662
18,555
26,483
33,998
55,055
55,05533,99826,48318,55511,662
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 00000



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue360,319
Cost of Revenue-326,617
Gross Profit33,70233,702
 
Operating Income (+$)
Gross Profit33,702
Operating Expense-349,351
Operating Income10,968-315,649
 
Operating Expense (+$)
Research Development0
Selling General Administrative2,010
Selling And Marketing Expenses0
Operating Expense349,3512,010
 
Net Interest Income (+$)
Interest Income6,929
Interest Expense-1,529
Other Finance Cost-122
Net Interest Income5,278
 
Pretax Income (+$)
Operating Income10,968
Net Interest Income5,278
Other Non-Operating Income Expenses0
Income Before Tax (EBT)30,64910,968
EBIT - interestExpense = -1,529
21,057
22,586
Interest Expense1,529
Earnings Before Interest and Taxes (EBIT)032,178
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax30,649
Tax Provision-7,463
Net Income From Continuing Ops23,18623,186
Net Income21,057
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-5,278
 

Technical Analysis of Eiko Lifesciences Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Eiko Lifesciences Ltd. The general trend of Eiko Lifesciences Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Eiko Lifesciences Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Eiko Lifesciences Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Eiko Lifesciences Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 58.50 < 61.99 < 65.90.

The bearish price targets are: 55.95 > 50.00 > 48.52.

Know someone who trades $EIKO? Share this with them.๐Ÿ‘‡

Eiko Lifesciences Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Eiko Lifesciences Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Eiko Lifesciences Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Eiko Lifesciences Ltd.

Eiko Lifesciences Ltd Daily Moving Average Convergence/Divergence (MACD) ChartEiko Lifesciences Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Eiko Lifesciences Ltd. The current adx is .

Eiko Lifesciences Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Eiko Lifesciences Ltd.

Eiko Lifesciences Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Eiko Lifesciences Ltd.

Eiko Lifesciences Ltd Daily Relative Strength Index (RSI) ChartEiko Lifesciences Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Eiko Lifesciences Ltd.

Eiko Lifesciences Ltd Daily Stochastic Oscillator ChartEiko Lifesciences Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Eiko Lifesciences Ltd.

Eiko Lifesciences Ltd Daily Commodity Channel Index (CCI) ChartEiko Lifesciences Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Eiko Lifesciences Ltd.

Eiko Lifesciences Ltd Daily Chande Momentum Oscillator (CMO) ChartEiko Lifesciences Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Eiko Lifesciences Ltd.

Eiko Lifesciences Ltd Daily Williams %R ChartEiko Lifesciences Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of Eiko Lifesciences Ltd.

Eiko Lifesciences Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Eiko Lifesciences Ltd.

Eiko Lifesciences Ltd Daily Average True Range (ATR) ChartEiko Lifesciences Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Eiko Lifesciences Ltd.

Eiko Lifesciences Ltd Daily On-Balance Volume (OBV) ChartEiko Lifesciences Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Eiko Lifesciences Ltd.

Eiko Lifesciences Ltd Daily Money Flow Index (MFI) ChartEiko Lifesciences Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Eiko Lifesciences Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-07-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-08-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-08-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-09-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Eiko Lifesciences Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Eiko Lifesciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose54.750
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Eiko Lifesciences Ltd with someone you think should read this too:
  • Are you bullish or bearish on Eiko Lifesciences Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Eiko Lifesciences Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Eiko Lifesciences Ltd

I send you an email if I find something interesting about Eiko Lifesciences Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Eiko Lifesciences Ltd.

Receive notifications about Eiko Lifesciences Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.